Education
About Us
Working with TipRanks
Follow Us
Progyny (PGNY)
NASDAQ:PGNY
PGNY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.39 - $32.99
Previous CloseN/A
Volume466.97K
Average Volume (3M)1.19M
Market Cap
$2.00B
Enterprise Value$1.33B
Total Cash (Recent Filing)-$4.69M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)41.3
Beta0.71
Next Earnings
Jul 31, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.17
Shares Outstanding85,668,390
10 Day Avg. Volume814,193
30 Day Avg. Volume1,192,209
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.66
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda19.23
Forecast
1Y Price Target
$27.83Price Target Upside18.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
---
Progyny News
PremiumCompany Announcements
Progyny Director Fred Cohen to Step Down
---
Bulls Say, Bears Say
Bulls Say
Market SharePGNY is expected to gain significant market share, with health plans generally viewing it as high-quality and reasonably priced.
Revenue PerformancePGNY slightly outperformed its quarterly guidance with a pre-announcement and then meaningfully outperformed the pre-announcement.
Bears Say
EBITDA GuidanceImplied adjusted EBITDA margin guidance is a little light versus estimates and consensus with the 16% midpoint a percentage point below FY24 margin of 17%.
Unemployment ImpactThe decline in consumption reported by PGNY may have been impacted by an increase in the unemployment rate.
---
Ownership Overview
8.30% Insiders
29.72% Mutual Funds
1.57% Other Institutional Investors
33.72% Public Companies and
Individual Investors
PGNY FAQ
What was Progyny’s price range in the past 12 months?
Progyny lowest stock price was $13.39 and its highest was $32.99 in the past 12 months.
What is Progyny’s market cap?
Progyny’s market cap is $2.00B.
When is Progyny’s upcoming earnings report date?
Progyny’s upcoming earnings report date is Jul 31, 2025 which is in 83 days.
How were Progyny’s earnings last quarter?
Progyny released its earnings results on May 08, 2025. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.19 by -$0.02.
Is Progyny overvalued?
According to Wall Street analysts Progyny’s price is currently Undervalued.
Does Progyny pay dividends?
Progyny does not currently pay dividends.
What is Progyny’s EPS estimate?
Progyny’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Progyny have?
Progyny has 85,668,390 shares outstanding.
What happened to Progyny’s price movement after its last earnings report?
Progyny reported an EPS of $0.17 in its last earnings report, missing expectations of $0.19. Following the earnings report the stock price went down -1.53%.
Which hedge fund is a major shareholder of Progyny?
Currently, no hedge funds are holding shares in PGNY
---
Progyny Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.83 (18.83% Upside)
$27.83 (18.83% Upside)
Blogger Sentiment
Bullish
PGNY Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 762.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $5.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-27.90%
12-Months-Change
Fundamentals
Return on Equity
11.14%
Trailing 12-Months
Asset Growth
-19.80%
Trailing 12-Months
Company Description
Progyny
Progyny, Inc. is a leading fertility benefits management company in the United States. It specializes in providing comprehensive fertility and family building solutions through its proprietary benefits plan, Progyny Smart Cycle, which covers a wide range of services including in vitro fertilization (IVF), egg freezing, and adoption. The company serves large self-insured employers by offering tailored programs that aim to improve clinical outcomes and reduce healthcare costs, helping employees achieve successful pregnancies and healthy births.
---
PGNY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive end to 2024 with strong revenue and client growth, high client retention, and successful new product launches. However, challenges include the loss of a major client, potential lower utilization rates, and increased investments impacting margins. Overall, the highlights outweigh the lowlights, indicating a positive outlook despite some hurdles.Read More>---
PGNY Stock 12 Month Forecast
Average Price Target
$27.83
▲(18.83% Upside)
Technical Analysis
---